Drugs & Medicine Recalls

Pharmaceutical recall notices, chemical impurities, and biological contamination.

Showing 24 of 400 results
Pharmaceutical
FDA DrugsClass II

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx On...

Lack of Assurance of Sterility

Mar 25, 2026Apotex Corp.
Pharmaceutical
FDA DrugsClass II

Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bott...

Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.

Mar 25, 2026STRIDES PHARMA INC
Pharmaceutical
FDA DrugsClass I

Webcol Alcohol Prep pad (70% isopropyl alcohol) 2 ply, 200 count boxes, Cardinal...

Non-Sterility: microbial contamination identified as Paenibacillus phoenicis

Mar 25, 2026Cardinal Health 200, LLC
Pharmaceutical
FDA DrugsClass III

Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured ...

Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg

Mar 25, 2026Annora Pharma Private Limited
Pharmaceutical
FDA DrugsClass II

Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 ...

Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.

Mar 25, 2026SOMERSET THERAPEUTICS LLC
Pharmaceutical
FDA DrugsClass II

Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured...

Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

Mar 18, 2026Zydus Pharmaceuticals (USA) Inc
Pharmaceutical
FDA DrugsClass II

Green Guard Antiseptic Wipes (Benzalkonium Chloride 0.13%), 25 wipes per box, Di...

CGMP Deviations

Mar 11, 2026ACME UNITED CORPORATION
Pharmaceutical
FDA DrugsClass II

Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: ...

Failed Dissolution Specifications

Mar 11, 2026Teva Pharmaceuticals USA, Inc
Pharmaceutical
FDA DrugsClass II

Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), R...

Defective container; inadequately sealed blister packaging.

Mar 11, 2026The Harvard Drug Group LLC
Pharmaceutical
FDA DrugsClass II

Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley ...

Lack of Assurance of Sterility

Mar 11, 2026New Life Pharma LLC
Pharmaceutical
FDA DrugsClass II

Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescript...

Failed Dissolution Specifications

Mar 11, 2026MYLAN PHARMACEUTICALS INC
Pharmaceutical
FDA DrugsClass II

Dynarex, BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 100 packets, 5...

CGMP Deviations

Mar 11, 2026ACME UNITED CORPORATION
Pharmaceutical
FDA DrugsClass II

WP WipesPlus Hand Sanitizing Wipes (Benzalkonium Chloride 0.13%), 5x7, 100 CT, P...

CGMP Deviations

Mar 11, 2026ACME UNITED CORPORATION
Pharmaceutical
FDA DrugsClass II

Children's Healthcare of Atlanta, Instant Hand Sanitizing Wipe(Benzalkonium Chlo...

CGMP Deviations

Mar 11, 2026ACME UNITED CORPORATION
Pharmaceutical
FDA DrugsClass II

Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Val...

Lack of Assurance of Sterility

Mar 11, 2026New Life Pharma LLC
Pharmaceutical
FDA DrugsClass II

First Aid Only BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) 100 Wipes...

CGMP Deviations

Mar 11, 2026ACME UNITED CORPORATION
Pharmaceutical
FDA DrugsClass II

Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; ...

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Mar 11, 2026Harbin Jixianglong Biotech Co., Ltd.
Pharmaceutical
FDA DrugsClass II

MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Sour...

Stability Data Does Not Support Expiry Date.

Mar 11, 2026HTO Nevada Inc. dba Kirkman
Pharmaceutical
FDA DrugsClass II

Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: ...

Failed Dissolution Specifications

Mar 11, 2026Teva Pharmaceuticals USA, Inc
Pharmaceutical
FDA DrugsClass I

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works...

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Mar 11, 2026ANTHONY TRINH, 123Herbals LLC
Pharmaceutical
FDA DrugsClass II

Savannah Antibacterial Towelettes (Benzalkonium Chloride 0.13%), 1 towelette, 4 ...

CGMP Deviations

Mar 11, 2026ACME UNITED CORPORATION
Pharmaceutical
FDA DrugsClass II

Medi-First Antiseptic Wipes (BZK)(Benzalkonium Chloride 0.13%), 100 wipes per bo...

CGMP Deviations

Mar 11, 2026ACME UNITED CORPORATION
Pharmaceutical
FDA DrugsClass II

First Aid Only BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 50 Wipes...

CGMP Deviations

Mar 11, 2026ACME UNITED CORPORATION
Pharmaceutical
FDA DrugsClass II

Med-Nap Cleansing Towelettes (Benzalkonium Chloride 0.13%), 100 Towelettes, Manu...

CGMP Deviations

Mar 11, 2026ACME UNITED CORPORATION